Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

N-Desethyl Sunitinib (hydrochloride) (Standard)

Glycochenodeoxycholic acid sodium salt (Standard) is the analytical standard of Glycochenodeoxycholic acid sodium salt. This product is intended for research and analytical applications. Glycochenodeoxycholic acid sodium salt (Sodium glycochenodeoxycholate) is a relatively toxic bile salt generated in the liver from chenodeoxycholic acid and glycine. Glycochenodeoxycholic acid sodium salt inhibits Autophagosome formation and impairs lysosomal function by inhibiting lysosomal proteolysis and increasing lysosomal pH in human normal liver cells, leading to the Apoptosis of human hepatocyte cells. Glycochenodeoxycholic acid sodium salt induces stemness and chemoresistance via activating STAT3 signaling pathway in hepatocellular carcinoma cells (HCC) . Glycochenodeoxycholic acid sodium salt is promising for research in the field of cholestasis desease, hepatocellular carcinoma and primary sclerosing cholangitis (PSC) [1][2][3][4].

Product Specifications

Product Name Alternative

SU-12662 (hydrochloride) (Standard)

UNSPSC

12352005

Target

Drug Metabolite; Reference Standards

Related Pathways

Metabolic Enzyme/Protease; Others

Field of Research

Cancer

Smiles

O=C1NC2=CC=C(F)C=C2/C1=C/C3=C(C)C(C(NCCNCC)=O)=C(C)N3.[H]Cl

Molecular Formula

C20H24ClFN4O2

Molecular Weight

406.88

References & Citations

[1]Sun L, et al. Discovery of 5-[5-fluoro-2-oxo-1,2- dihydroindol- (3Z) -ylidenemethyl]-2,4- dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl) amide, a novel tyrosine kinase inhibitor targeting vascular endothelial and platelet-derived growth factor receptor tyrosine kinase. J Med Chem. 2003;46 (7) :1116-1119.|[2]Mendel DB, et al. In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship. Clin Cancer Res. 2003;9 (1) :327-337.|[3]O'Farrell AM, et al. SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo. Blood. 2003;101 (9) :3597-3605.

Shipping Conditions

Room temperature

Scientific Category

Reference Standards

More Discoveries

Explore Other Products

Browse additional items from our catalog

SERPINE1 Antibody
OACD06275-1ML 1 mL

SERPINE1 Antibody

Sign In for Pricing
View Details
SKAR Polyclonal Antibody, FITC Conjugated
bs-7922R-FITC 100 µL

SKAR Polyclonal Antibody, FITC Conjugated

Sign In for Pricing
View Details
Lentiviral human WDR17 shRNA (UAS) - Lentiviral human WDR17 shRNA (UAS, iRFP) (25)
GTR15107882 1 Vial

Lentiviral human WDR17 shRNA (UAS) - Lentiviral human WDR17 shRNA (UAS, iRFP) (25)

Sign In for Pricing
View Details
TEA domain family member 2 (TEAD2) Human shRNA Plasmid Kit (Locus ID 8463)
TL308887 1 Kit

TEA domain family member 2 (TEAD2) Human shRNA Plasmid Kit (Locus ID 8463)

Sign In for Pricing
View Details
RAPGEF5 Protein Vector (Rat) (pPM-C-HA)
38508026 500 ng

RAPGEF5 Protein Vector (Rat) (pPM-C-HA)

Sign In for Pricing
View Details
GluR1a (Glutamate Receptor)
MBS622555-01 0.1 mL

GluR1a (Glutamate Receptor)

Sign In for Pricing
View Details